CPHI China 2025 | Empowering Global Pharmaceutical Partnerships Through Innovation

發(fā)布時(shí)間： 2025-06-27 閱讀：59次

分享

From June 24 to 26, the 23rd edition of CPHI China was successfully held in Shanghai. As a global leader in innovation-driven API partnerships, Dorra leveraged this premier platform to comprehensively showcase its strengths across self-developed APIs and intermediates, an extensive global supply chain, an integrated CDMO service platform, and strategic License-in collaborations. The event attracted widespread attention and in-depth discussions with customers worldwide, resulting in fruitful partnerships and laying a robust foundation for Dorra’s continued global expansion.

Spotlight on Innovation: Driving a Surge of Global Engagement

During the exhibition, Dorra’s booth remained a center of high activity, welcoming over 200 new and long-standing partners from core markets across Europe, the Americas, and Asia-Pacific. Visitors represented a dynamic mix of innovative pharmaceutical companies, major generic manufacturers, and regional distributors.

Centering on critical topics such as enhancing global supply chain resilience, accelerating joint development of proprietary products, implementing one-stop CDMO solutions, and advancing high-value licensing-in strategies, Dorra’s professional team engaged in productive, strategic dialogues with industry peers. The team’s expertise and responsiveness earned high recognition, fostering substantial cooperation intentions and paving the way for deeper partnerships.

Creating Value: Elevating Global Pharmaceutical Collaboration

For Dorra, CPHI China served not only as a showcase but as a strategic hub to deepen global partnerships, explore cutting-edge technologies, and collectively shape the industry’s future.

Through our breakthroughs in complex synthesis, continuous flow manufacturing, and enzyme catalysis, coupled with proprietary products and sharp market insights, Dorra highlighted its robust R&D engine, agile large-scale production capabilities, and fully traceable global supply chain.

This robust display reinforced Dorra’s strategic positioning as an innovation-driven API partner, highlighting its indispensable role in advancing global healthcare collaboration. 

Together Toward a Healthier Future: Driving Efficiency and Collaboration

We extend our heartfelt gratitude to our global partners for their continued trust and deep engagement. Looking ahead, Dorra will stay focused on delivering value through operational excellence, robust R&D, and an optimized global network.

Committed to our mission of creating more valuable products for human health, we will continue to explore high-value APIs and advanced technology solutions with partners worldwide, shaping new opportunities for innovation and quality growth in the pharmaceutical industry.

Next up for Dorra: CPHI Worldwide Frankfurt in October, We look forward to reconnecting and advancing global collaboration together.